| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5885884 | Journal of Critical Care | 2013 | 5 Pages |
Abstract
We found no difference in efficacy and safety outcomes when comparing iNO and iEPO in hypoxic, critically ill patients. Inhaled epoprostenol is associated with less drug expenditure than iNO.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Heather PharmD, BCPS, Paul M. PharmD, BCPS, Kevin E. PharmD, BCPS, Paul MS, RRT, FAARC, Susan RRT, Gerald MD,